|
Market Report
|
New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. However, despite the costs and risks involved in drug development, the pharma industry is finding new ways to streamline the R&D process in an effort to increase efficiency and output.
|
|
Read more...
|
|
|
Market Report
|
Osteoporosis - Novel agents to battle for payer acceptance
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong performance of the bisphosphonate class.
|
|
Read more...
|
|
|
Market Report
|
Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
While existing treatment strategies for adult acute leukemia may yield satisfactory remission- induction rates, a major clinical concern is the high rate of disease relapse despite attempts to optimize post-remission consolidation therapy. This is acutely problematic among elderly patients who are frequently unable to tolerate the rigors of more intensive treatment approaches.
|
|
Read more...
|
|
|
Market Report
|
The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
This report provides comprehensive coverage of every class of drugs across major cardiovascular indications and profiles the underlying trends and factors driving the market. Detailed insights into recent key events and future market leaders are also provided, in addition to epidemiological analysis and forecasts for major products over the 2007-13 period.
|
|
Read more...
|
|
|
Market Report
|
Diabetes to the fore as generics hit primary care markets
Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.
|
|
Read more...
|
|
|
Market Report
|
Commercial strategies in cardiovascular and metabolic diseases-successful market positioning at company and brand level becomes paramount
Datamonitor expects commercial strategies in the cardiovascular and metabolic markets to become increasingly important as the markets mature. The report details strategies used by pharmaceutical companies to capture market share, to differentiate brands from the competition, for revenue maximization and for the defense of brand revenues from generic competition.
|
|
Read more...
|
|
|
Market Report
|
Technology Transfer Strategies: Maximizing the returns from new technologies
Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, recent trends have shown improvements in staffing, expertise and service levels.
|
|
Read more...
|
|
|
Market Report
|
The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Autoimmune disorders have been one of the most prominent growth segments in the pharma industry over the last decade. A growing patient population and high levels of unmet need are the main drivers of market growth, and novel biologics are increasingly helping to fulfill patient need, with their high cost helping to drive market sales.
|
|
Read more...
|
|
|
Market Report
|
Market developments, outsourcing hotspots and growth strategies
This report aims to identify the hotspots and profile the leading players in the global pharmaceutical contract manufacturing market.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 55 - 63 of 324 |
Farmavita.Net Journal 
